Generex appoints chief compliance officer
Title: Generex appoints a CCOGenerex Biotechnology, a biopharmaceutical company, has named Anthony Crisci as general manager, chief compliance officer, and corporate counsel for all of NuGenerex’s distribution efforts.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
OpinionEthics as strategic value: When compliance becomes a board-level decision tool
For many Boards of Directors, compliance reporting feels familiar and reassuring. Dashboards are green. Policies are updated. Training is complete. Incidents are investigated and closed. On paper, the system works.
-
OpinionWhy “just do the work” fails in regulated organizations
Most organizational failures are not failures of effort, discipline, or follow-through. They are interpretation failures misdiagnosed as execution problems.
-
PremiumNominations open for Compliance Week’s 2026 “Excellence in Compliance Awards”
Back for its seventh year, Compliance Week’s Excellence in Compliance Awards seek to honor the CCOs, compliance programs, trail-blazers, industry veterans, mentors and up-and-coming professionals who set the standard for compliance in 2026.